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Synthesis and processing of radiolabelled rat insulin I and II were studied by pulse-labelling freshly isolated 
rat islets with PH]leucine and chasing in 2 mM glucose for up to 270 min (which minimized insulin secre- 
tion, < 1%/h). Islet samples were taken during the chase period and analyzed for their rat insulin I and II 
content by high-performance liquid chromatography. Prior to 60 min chase rat insulin I accounted for 
> 85% of the radiolabelled insulin present. With longer periods of chase, the relative percentage of rat insulin 
II progressively increased so that by completion of proinsulin to insulin processing the two labelled rat insu- 
lins were present in the same proportion as the relative immunoreactive content, approx. 6040% insulin 
I/ insulin II. Thus, although islets synthesize the two insulins in proportion to their relative immunoreactive 
content, rat insulin I and II are processed with different kinetics. 
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1. INTRODUCTION 
The importance of protein structure in 
regulating processing is supported by the observed 
differences in the rates of maturation of various 
secretory proteins in tumor [1,2] and normal cells 
[3]. Processing of secretory proteins involves 
multiple events including intracellular transport 
and enzymatic modification of the proteins. Each 
of these steps can in turn perform a regulatory 
function in the maturation process. 
Rat islets of Langerhans contain two insulins 
(1,II) [4,5] that are products of non-allelic genes 
[6,7]. Translation of the two insulin mRNAs 
results in the synthesis of two preproinsulins dif- 
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fering by 7 amino acids. Processing of these pep- 
tides involves removal of the pre region and 
formation of proinsulins differing in 4 of 86 amino 
acids. The proinsulins are then transported from 
the ER, through the Golgi and sequestered into 
secretory granules [8]. Within the granules the pro- 
insulins are cleaved to mature insulins I and II [9] 
which have identical A chains but differ by 2 
amino acids in the B chain (positions 9,29 [7]). 
Although freshly isolated islets from normal rats 
contain the two insulins in approx. 60% insulin I, 
40% insulin II proportions [5,10], alterations in 
this distribution have been reported [l l-131. Fur- 
thermore, controversy exists as to whether glucose 
(the primary physiologic regulator of insulin syn- 
thesis and secretion) can differentially regulate the 
levels of the two hormones [S,ll, 131. Thus rat 
islets of Langerhans offer a unique opportunity to 
investigate regulation of synthesis and processing 
of two highly homologous proteins in normal 
tissue. Experiments were designed to investigate: 
(i) the effect of acute glucose stimulation on the 
translational synthesis of the two insulins and (ii) 
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the temporal aspects of individual rat insulins I 
and II processing. 
In this report we demonstrate that in freshly 
isolated islets from normal rats: (i) acute glucose 
exposure stimulates the synthesis of both insulins 
in proportion to their immunoreactive content and 
(ii) differences in the amino acid structure of the 
two proinsulins appear to confer a selectivity in the 
processing mechanism resulting in differential 
rates of rat insulin I and II maturation. 
2. MATERIALS AND METHODS 
Islets of Langerhans from adult male rats (Long 
Evans) were isolated by 3 sequential digestions of 
pancreas with collagenase followed by Percoll gra- 
dients as described [14]. All islet incubations were 
performed at 37°C in Krebs-Ringer bicarbonate 
buffer (KRB) containing 10 mM Hepes, pH 7.4, 
0.1% bovine serum albumin and either 2 or 20 mM 
glucose. Groups of 40-150 islets were prein- 
cubated for 45 min in KRB containing 20 mM 
glucose (to stimulate translational synthesis of pro- 
insulin [15,16]) then pulsed for 15-20 min with 
0.25 mCi L-[4,5-3H]leucine, also in 20 mM glucose 
KRB. Following the pulse, secretion of newly syn- 
thesized insulin was minimized by washing islets 
with 2 mM glucose KRB containing 0.2 mM cold 
leucine and incubating in this media for up to 
275 min. During culture in 2 mM glucose KRB, 
islets secreted less than 1% of their total insulin 
content per hour. As part of another investigation 
(to be described elsewhere), a 40 min glucose 
stimulation was introduced at 150 min. Therefore, 
for this study, data used to calculate the rat insulin 
I and II percentages (at 190 and 290 min) were a 
result of combining islet and glucose-stimulated 
media measurements. 
Collected samples were immediately frozen in 
microcentrifuge tubes then lyophilized over a 4-h 
period. As described elsewhere (in preparation), 
following lyophilization, samples were redissolved 
and extracted in 1 M acetic acid then twice frozen, 
thawed, sonicated and centrifuged for 5 min in an 
Eppendorf microfuge. 50-100~1 aliquots of the 
supernatant were subjected to gradient elution 
reverse-phase HPLC using a Dupont PEP-R C-8 
column with a 32-35% acetonitrile/water gradient 
over 35 min and a flow rate of 1 ml/min. Both 
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mobile phases (water and acetonitrile) contained 
0.1% trifluoroacetic acid and 0.1% morpholine. 
Absorbance, radioactivity and insulin im- 
munoreactivity [17] were measured in 1 min frac- 
tions (fig.1). In addition, 100 ,ul aliquots from 
20 min and 290 min chase time samples were af- 
finity purified [14] and total insulin related 
radioactivity (insulin + proinsulin) determined. 
3. RESULTS 
Fig.1 is a schematic HPLC elution profile 
demonstrating the separation of the two rat in- 
sulins from [3H]leucine labelled islets. Rat insulin 
I and II are resolved as two major peaks of absor- 
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Fig.1. Schematic representation of rat insulin I and II 
separation in pulse-chased islets using reverse-phase 
HPLC with a 32-35% acetonitrile gradient over 35 min. 
The top panei depicts the absorbance elution recording 
at a wavelength of 215 nm. The middle panel represents 
the radioactivity elution profile and the bottom panel is 
the corresponding IRI measurements for each fraction. 
Under these conditions rat insulin II elutes first at 
21-25 min followed by a broader rat insulin I peak at 
21-34 min. 
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bance (at 215 nm) corresponding to major peaks 
of both radioactivity and IRI. The identity of each 
insulin peak was determined (in preparation) by 
using islets labelled with [‘?S]methionine (only rat 
insulin II contains methionine in its amino acid 
structure [7]; this label appeared solely in the peak 
eluting at 21-25 min). The purity of each peak was 
confirmed using polyacrylamide gel elec- 
trophoresis fluorography [ 181. This analysis 
revealed that the fractions within each peak con- 
tained a single radioactive band with a molecular 
mass identical to that of purified insulin standards. 
In all samples analyzed, rat insulin I and II peaks 
accounted for greater than 83% of the total IRI in 
each original sample. Under these conditions, us- 
ing HPLC purified labelled insulin I and II stan- 
dards, recovery of radioactivity for both insulins 
was greater than 95% while the recovered IRI 
ranged between 78 and 93%. 
Under the incubation conditions illustrated in 
fig.2 (which we previously reported to result in a 
net proinsulin to insulin conversion half-life of 
50 min [ 141) the relative appearance of labelled rat 
insulin I and II occurs with different kinetics. At 
early chase times when initial conversion of la- 
belled proinsulin to insulin begins, rat insulin I is 
the predominant radioactive insulin; prior to the 
60 min chase time it accounts for greater than 85 % 
of the radioactive insulin present. At later chase 
times, with continued proinsulin to insulin conver- 
sion, the relative proportion of rat insulin II in- 
creases so that by 150 min chase, when insulin 
maturation nears completion, the intra-islet 
radioactive insulin distribution approaches the IRI 
distribution we find in freshly isolated untreated 
islets (insulin I = 58.4%, insulin II = 41.6070, SE + 
2.8%). Furthermore, similar amounts of total 
radioactive IRI (insulins + proinsulins; after cor- 
rection for loss due to C peptide excision) were 
recovered at the beginning and end of these ex- 
periments (3.3 x 10m3 cpm at 20 min, 3.5 x 
10m3 cpm at 290 min) indicating that the proin- 
sulins must have been originally synthesized in a 
60 : 40% I/II proportion. Thus, differential 
biosynthesis or degradation of rat insulin I or II 
cannot explain the observed differences in the 
disproportionate amounts of the two insulins at 
early chase times. 
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4. DISCUSSION 
The stimulatory effect of glucose on total insulin 
synthesis has long been recognized, however, con- 
troversy exists as to its relative effect on regulating 
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Fig.2. Effect of time on percent contribution of labelled rat insulin I and II (bars) to the total labelled insulin. The bar 
graph depicts the percent of rat insulin I and II at each time. The dashed line represents he total percent of newly 
synthesized insulin appearance over time. Percentage is calculated and normalized to the amount of radioactive IRI at 
the 20 min (0%) and 290 min (100%) chase times. Similar amounts of radioactive IRI were present at both these time 
points (after correction for the loss of radioactivity due to C peptide excision at 290 min). 
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rat insulin I and II biosynthesis. Previously in- 
vestigators, using electrophoresis to separate the 
two insulins, reported that incubating freshly 
isolated islets in 16.0 mM glucose for 4 h resulted 
in an 8-fold greater synthesis of rat insulin I than 
II [ll, 121. Subsequently, others observed that in 
islets cultured overnight, glucose stimulates the 
synthesis of both insulins to the same extent [ 131. 
In this study we report that acute exposure (45 min 
preincubation) of freshly isolated islets to 20 mM 
glucose (which at such short times is known to act 
primarily at the translational evel), stimulates net 
biosynthesis of the two rat insulins in approximate- 
ly a 60% insulin I to 40% insulin II manner. This 
rat insulin I/II distribution is the same as the IRI 
content of untreated freshly isolated islets ([5,10] 
and personal observation) and is consistent with 
the previously reported in vivo effect of glucose on 
insulin I and II mRNA levels [ 191. 
We also observed that rat insulin I and II 
maturation occurs with different kinetics. These 
data indicate that events involved in processing of 
the two insulins are differentially affected by dif- 
ferences in their amino acid structure. 
In hepatoma cells [1,2] and hepatocytes [3], the 
regulatory step in determining the maturation rate 
of each protein appears to be its rate of transport 
from the ER. Recently the presence of a specific 3 
amino acid sequence has been demonstrated to 
confer retention of a protein within the ER [20]. 
These studies have supported the contention that 
protein transport from the ER to the Golgi ap- 
paratus is a highly regulated process and occurs via 
a yet uncharacterized receptor(s) recognition 
mediated mechanism [21]. 
Proteolysis is another potential site of regula- 
tion. Converting enzymes are present in many cell 
types and may represent a ubiquitous set of pro- 
teins [22]. Transfection of the insulin gene into 
non-insulin producing secretory tumor cells has 
demonstrated that non B-cells are capable of syn- 
thesizing and converting proinsulin to insulin [23]. 
However, the observation that a single amino acid 
substitution at position 10 within the B chain (His 
to Asp), which is not at the proinsulin cleavage 
point, results in a hyperproinsulinemic state in vivo 
[24] suggests that enzymes responsible for proin- 
sulin to insulin conversion in normal B-cells (pro 
cathepsin B? 125,261) exhibit selectivity toward 
particular proinsulin conformations. 
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In summary, our data support the theory that, in 
islets, acute glucose exposure stimulates the syn- 
thesis of the two insulins to the same extent, in pro- 
portion to their basal immunoreactive content and 
reported level of mRNA. Furthermore, amino acid 
substitutions within the proinsulins result in dif- 
ferent kinetics of rat insulin I and II maturation. 
The mechanisms responsible for these differences 
and their regulation remain to be determined. 
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